We have confirmed that indeed moDCs show maturation features when in the presence of supernatant of tumor cells treated with the highly cytotoxic NB-PDT, including upregulation of the maturation markers CD86 and MHC II (Figure 5a,b) and increased secretion of IL12-p40, IL-1β, and IL-10 (Figure 5c,d). This evidence concerns the gene CD86 and neoplasm.